Target intelligence / Profile preview

Human cytomegalovirus virulence factors (HCMV virulence factors)

Target
HCMV virulence factors
Molecular classification
Viral protein, Enzyme, Transcription factor, Immune modulator
01

Overview

Human cytomegalovirus (HCMV) virulence factors are a collection of viral proteins that are essential for the virus's ability to replicate, spread, and persist within a host. These factors include the UL54 DNA polymerase, which synthesizes viral DNA, and the UL97 protein kinase, which is necessary for viral egress and the activation of certain antiviral agents (StatPearls, 2023). Another critical virulence factor is the viral terminase complex (comprising UL56, UL89, and UL51), which facilitates the cleavage and packaging of viral DNA into capsids (FDA, 2017). Additionally, HCMV encodes proteins such as US2, US3, US6, and US11 that actively subvert the host's immune response by downregulating MHC class I and II molecules (UniProt). Because these proteins are vital for the viral life cycle and differ significantly from human proteins, they serve as the primary targets for antiviral drugs like ganciclovir, letermovir, and maribavir (NEJM, 2021). Inhibition of these factors is the cornerstone of managing CMV disease in immunocompromised populations, such as transplant recipients and HIV patients.

Other names
HCMV proteinsHHV-5 virulence factorsCytomegalovirus pathogenicity factorsHCMV gene products
02

Mechanism of action

Inhibition of viral DNA polymerase (UL54), inhibition of viral terminase complex (UL56), and inhibition of viral protein kinase (UL97).

03

Biological functions

Viral replicationImmune evasionViral entryDNA packagingViral egress
04

Disease associations

Infection
05

Safety considerations

MyelosuppressionNephrotoxicityElectrolyte imbalancesTeratogenicityAntiviral resistance
06

Interacting drugs

Ganciclovir

5 more in the full profile.

07

Biomarkers

CMV DNA PCRUL97 resistance mutationsUL54 resistance mutationsUL56 resistance mutationspp65 antigenemia

Beyond the preview

Go deeper on Human cytomegalovirus virulence factors (HCMV virulence factors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human cytomegalovirus virulence factors (HCMV virulence factors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call